Clinicopathologic Significance of Heat Shock Protein 60 as a Survival Predictor in Colorectal Cancer.

The role of heat shock protein 60 (HSP60), a mitochondrial chaperone, in tumor progression or its anti-tumor effects remains controversial. This study aimed to confirm the possibility of using HSP60 as a prognostic marker in patients with colorectal cancer (CRC), considering TNM classification for precise prediction. HSP60 expression increased with differentiation and p53 mutations in patients. However, compared to patients with high HSP60 expression, patients with low HSP60 expression had event-free survival and disease-specific survival hazard ratios (HRs) of 1.42 and 1.69, respectively. Moreover, when the survival rate was analyzed by combining TNM classification and HSP60 expression, the prognosis was poor, particularly when HSP60 expression was low in the late/advanced stage. This pattern was also observed with HSP family D member 1, HSPD1, the gene that encodes HSP60. Low HSPD1 expression was linked to lower overall survival and relapse-free survival rates, with HRs of 1.80 and 1.87, respectively. When TNM classification and HSPD1 expression were considered, CRC patients with low HSPD1 expression and advanced malignancy had a poorer prognosis than those with high HSPD1 expression. Thus, HSPD1/HSP60 can be a useful biomarker for a sophisticated survival prediction in late- and advanced-stage CRC, allowing the design of individualized treatment strategies.

[1]  S. Fan,et al.  The Multiple Roles and Therapeutic Potential of HSP60 in Cancer. , 2022, Biochemical pharmacology.

[2]  Adnan Khan,et al.  The Role of Heat Shock Proteins in Cellular Homeostasis and Cell Survival , 2021, Cureus.

[3]  Songbiao Zhu,et al.  HSP60-knockdown suppresses proliferation in colorectal cancer cells via activating the adenine/AMPK/mTOR signaling pathway , 2021, Oncology Letters.

[4]  Steven M. Johnson,et al.  Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancer. , 2021, Bioorganic & medicinal chemistry.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  A. Marino Gammazza,et al.  Hsp60 Post-translational Modifications: Functional and Pathological Consequences , 2020, Frontiers in Molecular Biosciences.

[7]  J. Kang,et al.  Clinical study of colorectal cancer operation: Survival analysis , 2020, Korean journal of clinical oncology.

[8]  H. Naim,et al.  Heat Shock Protein 60 in Hepatocellular Carcinoma: Insights and Perspectives , 2020, Frontiers in Molecular Biosciences.

[9]  A. Jemal,et al.  Colorectal cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[10]  C. Yeh,et al.  Functional Compartmentalization of HSP60-Survivin Interaction between Mitochondria and Cytosol in Cancer Cells , 2019, Cells.

[11]  F. Frizelle,et al.  A Review of the Role of Carcinoembryonic Antigen in Clinical Practice , 2019, Annals of coloproctology.

[12]  Yan Chen,et al.  The Clinical Value of HSP60 in Digestive System Cancers: a Systematic Review and Meta-Analysis. , 2019, Clinical Laboratory.

[13]  W. Lu,et al.  HSP60-regulated Mitochondrial Proteostasis and Protein Translation Promote Tumor Growth of Ovarian Cancer , 2019, Scientific Reports.

[14]  F. Bucchieri,et al.  Immunomorphological Pattern of Molecular Chaperones in Normal and Pathological Thyroid Tissues and Circulating Exosomes: Potential Use in Clinics , 2019, International journal of molecular sciences.

[15]  T. Fu,et al.  HSPD1 repressed E-cadherin expression to promote cell invasion and migration for poor prognosis in oral squamous cell carcinoma , 2019, Scientific Reports.

[16]  Yuling Chen,et al.  HSP60 silencing promotes Warburg-like phenotypes and switches the mitochondrial function from ATP production to biosynthesis in ccRCC cells , 2019, Redox biology.

[17]  C. Croce,et al.  Fhit–Fdxr interaction in the mitochondria: modulation of reactive oxygen species generation and apoptosis in cancer cells , 2019, Cell Death & Disease.

[18]  Prashanth Rawla,et al.  Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors , 2019, Przeglad gastroenterologiczny.

[19]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[20]  Jun Yin,et al.  UBXN2A enhances CHIP‐mediated proteasomal degradation of oncoprotein mortalin‐2 in cancer cells , 2018, Molecular oncology.

[21]  Kwang-Huei Lin,et al.  Targeting HSP60 by subcutaneous injections of jetPEI/HSP60‐shRNA destabilizes cytoplasmic survivin and inhibits hepatocellular carcinoma growth , 2018, Molecular carcinogenesis.

[22]  Hongwei Sun,et al.  Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth , 2018, Cell Death & Disease.

[23]  A. Marino Gammazza,et al.  Quantitative patterns of Hsps in tubular adenoma compared with normal and tumor tissues reveal the value of Hsp10 and Hsp60 in early diagnosis of large bowel cancer , 2016, Cell Stress and Chaperones.

[24]  F. Bucchieri,et al.  Heat shock protein 60 levels in tissue and circulating exosomes in human large bowel cancer before and after ablative surgery , 2015, Cancer.

[25]  J. Díaz-Villanueva,et al.  Protein Folding and Mechanisms of Proteostasis , 2015, International journal of molecular sciences.

[26]  Xiang Fu,et al.  Heat Shock Protein 60 Overexpression Is Associated with the Progression and Prognosis in Gastric Cancer , 2014, PloS one.

[27]  G. Poston,et al.  TNM staging of colorectal cancer should be reconsidered by T stage weighting. , 2014, World journal of gastroenterology.

[28]  R. Langer,et al.  A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas , 2013, British Journal of Cancer.

[29]  W. Ruan,et al.  HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma , 2010, Journal of experimental & clinical cancer research : CR.

[30]  Y. Hwang,et al.  Expression of Heat Shock Protein 60 kDa Is Upregulated in Cervical Cancer , 2009, Yonsei medical journal.

[31]  Kou-Juey Wu,et al.  Interaction between HSP60 and beta-catenin promotes metastasis. , 2009, Carcinogenesis.

[32]  P. Rouanet,et al.  Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. , 2008, Journal of proteome research.

[33]  Yuzhang Wu,et al.  Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer , 2007, Proteomics. Clinical applications.

[34]  K. Kihara,et al.  HSP60 may predict good pathological response to neoadjuvant chemoradiotherapy in bladder cancer. , 2006, Japanese journal of clinical oncology.

[35]  Lei Wang,et al.  Identification of breast cancer metastasis‐associated proteins in an isogenic tumor metastasis model using two‐dimensional gel electrophoresis and liquid chromatography‐ion trap‐mass spectrometry , 2006, Proteomics.

[36]  K. Miyazaki,et al.  Differential expression of Janus kinase 3 (JAK3), matrix metalloproteinase 13 (MMP13), heat shock protein 60 (HSP60), and mouse double minute 2 (MDM2) in human colorectal cancer progression using human cancer cDNA microarrays. , 2005, Pathology, research and practice.

[37]  F. Bucchieri,et al.  The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase , 2005, BMC Cancer.

[38]  H. Kuwano,et al.  Expression of heat-shock protein Hsp60 correlated with the apoptotic index and patient prognosis in human oesophageal squamous cell carcinoma. , 2004, European journal of cancer.

[39]  P. Mróz,et al.  Effective Photoimmunotherapy of Murine Colon Carcinoma Induced by the Combination of Photodynamic Therapy and Dendritic Cells , 2004, Clinical Cancer Research.

[40]  Torsten Hothorn,et al.  On the Exact Distribution of Maximally Selected Rank Statistics , 2002, Comput. Stat. Data Anal..

[41]  J. Schneider,et al.  Immunohistochemical detection of HSP60-expression in human ovarian cancer. Correlation with survival in a series of 247 patients. , 1999, Anticancer research.